Davis's Drug Guide
Simbrinza Ophthalmic Suspension
There's more to see -- the rest of this topic is available only to subscribers.
Citation
Vallerand, April Hazard., et al. "Simbrinza Ophthalmic Suspension." Davis's Drug Guide, 18th ed., F.A. Davis Company, 2023. Medicine Central, im.unboundmedicine.com/medicine/view/Davis-Drug-Guide/109913/all/Simbrinza_Ophthalmic_Suspension.
Vallerand AHA, Sanoski CAC, Quiring CC. Simbrinza Ophthalmic Suspension. Davis's Drug Guide. F.A. Davis Company; 2023. https://im.unboundmedicine.com/medicine/view/Davis-Drug-Guide/109913/all/Simbrinza_Ophthalmic_Suspension. Accessed May 29, 2023.
Vallerand, A. H., Sanoski, C. A., & Quiring, C. (2023). Simbrinza Ophthalmic Suspension. In Davis's Drug Guide (18th ed.). F.A. Davis Company. https://im.unboundmedicine.com/medicine/view/Davis-Drug-Guide/109913/all/Simbrinza_Ophthalmic_Suspension
Vallerand AHA, Sanoski CAC, Quiring CC. Simbrinza Ophthalmic Suspension [Internet]. In: Davis's Drug Guide. F.A. Davis Company; 2023. [cited 2023 May 29]. Available from: https://im.unboundmedicine.com/medicine/view/Davis-Drug-Guide/109913/all/Simbrinza_Ophthalmic_Suspension.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Simbrinza Ophthalmic Suspension
ID - 109913
A1 - Sanoski,Cynthia A,
AU - Vallerand,April Hazard,
AU - Quiring,Courtney,
BT - Davis's Drug Guide
UR - https://im.unboundmedicine.com/medicine/view/Davis-Drug-Guide/109913/all/Simbrinza_Ophthalmic_Suspension
PB - F.A. Davis Company
ET - 18
DB - Medicine Central
DP - Unbound Medicine
ER -
